HomeAbout UsContact Us
Advanced Search
All CoursesCourses by TopicCourses by SpecialtyCourses by Specialty CreditRegister Now!!
Register Now!!
Member Login
Your Account
Your Test History
Your Certificates
Your Payment History
All Courses
Courses by Topic
Courses by Specialty
Courses by Specialty Credit
Accreditation
State Requirements
FAQs
 
Home : Advanced Search : Course view :






Course: Improving Survival Rates by Surgical Resection of Colorectal Liver Metastases 


Specialty: Hematology/Oncology Format: Text 
Course #: 9831  Price: $20.00  
Release date: 2011-07-01  Valid through: 2014-07-01  
Publication: This activity originally appeared in Clinical Oncology Alert. 
Course viewing requirements (opens in a new window)
Instructions for Course Participation (opens in a new window)
Legal disclaimer (opens in a new window)


Target Audience:
This activity is intended for the oncologist.
Sponsor:
This activity is sponsored by AHC Media.
Accreditation:
AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation:
AHC Media designates this enduring material for a maximum of 2 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Faculty
Editor
William Ershler, MD
INOVA Fairfax Hospital Cancer Center, Fairfax, VA;
Director, Institute for Advanced Studies in Aging
Washington, DC

Authors
Jerome W. Yates, MD
National Institute on Aging, NIH

Andrew S. Artz, MD
Hematology/Immunology Unit
National Institute on Aging, NIH

Peer Reviewer
V.R. Veerapalli, MD
Staff Clinician, INOVA Fairfax Cancer Center
Falls Church, VA


Subjects:
  • Improving Survival Rates by Surgical Resection of Colorectal Liver Metastases
  • Colorectal Adjuvant Chemotherapy: Timing Is Something
  • CML Treatment in the Elderly: Imatinib Levels the Playing Field
  • Population Screening for the Early ID of Prostate Cancer
  • Extranodal Marginal Zone Lymphoma
 
Objectives:
  • to present the latest information regarding diagnosis and treatment of various types of cancer
  • to present prevalence/surveillance data and long-term follow-up results of chemotherapy/radiation regimens
  • to describe new advances in the field of oncology
 
Financial Disclosure:
Editor
William Ershler, MD
INOVA Fairfax Hospital Cancer Center, Fairfax, VA;
Director, Institute for Advanced Studies in Aging
Washington, DC

Authors
Jerome W. Yates, MD
National Institute on Aging, NIH

Andrew S. Artz, MD
Hematology/Immunology Unit
National Institute on Aging, NIH

Peer Reviewer
V.R. Veerapalli, MD
Staff Clinician, INOVA Fairfax Cancer Center
Falls Church, VA
 
  • You are not currently logged in.
  • To view content articles and complete the post-test for this course, please login or register now

 



Copyright Notices  | Terms of Use  
Privacy Statement